Alosetron

In the US, Alosetron (alosetron systemic) is a member of the drug class serotoninergic neuroenteric modulators and is used to treat Diarrhea and Irritable Bowel Syndrome.

US matches:

• Alosetron


• Alosetron Hydrochloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A03AE01

CAS registry number (Chemical Abstracts Service)

0122852-42-0

Chemical Formula

C17-H18-N4-O

Molecular Weight

294

Therapeutic Categories

Antiemetic

Serotonin antagonist

Chemical Names

1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-

2,3,4,5-Tetrahydro-5-methyl-2-[(5-methylimidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one (WHO)

Foreign Names

• Alosetronum (Latin)
• Alosetron (German)
• Alosétron (French)
• Alosetrón (Spanish)

Generic Names

• Alosetron (OS: BAN)
• GR 68755X (IS: Glaxo)
• Alosetron Hydrochloride (OS: USAN, BANM)
• GR 68755C (IS: Glaxo)

Brand Names

• Lotronex
  GlaxoSmithKline, United States; Prometheus, United States

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.